Evidence map›Paper›PMID 25488301›Full record

ArticleJournal of bacteriology2015

Role of the Streptococcus mutans CRISPR-Cas systems in immunity and cell physiology.

M A Serbanescu, M Cordova, K Krastel, R Flick, N Beloglazova, A Latos, A F Yakunin, D B Senadheera, D G Cvitkovitch

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Transcription regulator TrtA modulates oxygen stress response inApplied and environmental microbiology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. CcpA and CodY Regulate CRISPR-Cas System ofMicrobiology spectrum · 2023
    Article
  12. Mechanisms regulating the CRISPR-Cas systems.Frontiers in microbiology · 2023
    Review
  13. Prospective Advances in Genome Editing Investigation.Advances in experimental medicine and biology · 2023
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Characterization of FtsH Essentiality inFrontiers in genetics · 2021
    Article
  19. [Transcriptomic Analysis ofSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2021
    Article
  20. New Insights onFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

M A SerbanescuDental Research Institute, Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
M CordovaDental Research Institute, Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
K KrastelDental Research Institute, Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
R FlickDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
N BeloglazovaDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
A LatosDental Research Institute, Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
A F YakuninDepartment of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
D B SenadheeraDental Research Institute, Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
D G CvitkovitchDental Research Institute, Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada d.cvitkovitch@dentistry.utoronto.ca.
University of Toronto · CA

Funding

The competence regulon in Streptococcus mutans biofilmsR01DE013230 · NIDCR · UNIVERSITY OF TORONTO · PI CVITKOVITCH, DENNIS G. · 1999 to 2011
$3.2M
Canadian Institutes of Health Research MT-15431NIDCR NIH HHS R01 DE013230NIDCR NIH HHS R01DE013230-03
6 · The paper itself

Abstract

CRISPR-Cas systems provide adaptive microbial immunity against invading viruses and plasmids. The cariogenic bacterium Streptococcus mutans UA159 has two CRISPR-Cas systems: CRISPR1 (type II-A) and CRISPR2 (type I-C) with several spacers from both CRISPR cassettes matching sequences of phage M102 or genomic sequences of other S. mutans. The deletion of the cas genes of CRISPR1 (ΔC1S), CRISPR2 (ΔC2E), or both CRISPR1+2 (ΔC1SC2E) or the removal of spacers 2 and 3 (ΔCR1SP13E) in S. mutans UA159 did not affect phage sensitivity when challenged with virulent phage M102. Using plasmid transformation experiments, we demonstrated that the CRISPR1-Cas system inhibits transformation of S. mutans by the plasmids matching the spacers 2 and 3. Functional analysis of the cas deletion mutants revealed that in addition to a role in plasmid targeting, both CRISPR systems also contribute to the regulation of bacterial physiology in S. mutans. Compared to wild-type cells, the ΔC1S strain displayed diminished growth under cell membrane and oxidative stress, enhanced growth under low pH, and had reduced survival under heat shock and DNA-damaging conditions, whereas the ΔC2E strain exhibited increased sensitivity to heat shock. Transcriptional analysis revealed that the two-component signal transduction system VicR/K differentially modulates expression of cas genes within CRISPR-Cas systems, suggesting that VicR/K might coordinate the expression of two CRISPR-Cas systems. Collectively, we provide in vivo evidence that the type II-A CRISPR-Cas system of S. mutans may be targeted to manipulate its stress response and to influence the host to control the uptake and dissemination of antibiotic resistance genes.

Indexed as

CRISPR-Cas SystemsBacterial ProteinsBacteriophagesClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Associated ProteinsMicrobial ViabilityStreptococcus mutansBacterial ProteinsCRISPR-Associated Proteins

Identifiers

PMID25488301
PMCPMC4334182
OpenAlexW2034201571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.